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Abstract
Background: There is growing awareness and clinical interest in athletes with affective symptoms after sport-related concussion (SRC), as these symptoms may
contribute to overall symptoms and represent a modifiable risk factor of longer
recovery. However, evidence of their effects on the entire return-to-play (RTP)
trajectory, particularly among women and men, is limited.
Purpose/Hypothesis: To examine the relationship between affective symptom reporting and RTP progression after SRC among a cohort of Division 1 studentathletes. We hypothesized that those endorsing affective symptoms, specifically
nervous-anxious symptoms, spend more time in RTP progression and recovery.
Study Design: Cohort study; Level of evidence, 3.
Methods: Using SRC data from the Ivy League–Big Ten Epidemiology of Concussion
Study among varsity athletes through February 2020, we identified the 4 affective symptoms from the Sport Concussion Assessment Tool symptom inventory.
We modeled the relationship between a 4-category affective symptom variable
and time to symptom resolution, RTP, and RTP progression, adjusting for nonaffective symptom prevalence and concussion history. Cox regressions were used
to estimate hazard ratios for time to event outcomes, and linear regressions were
used to evaluate mean differences for continuous outcomes.
Results: Among 2077 student-athletes (men, 63.5%) with SRC symptoms, affective
symptom prevalence was 47.6% and 44.3% in women and men, respectively, and
nervous-anxious prevalence was 24.2% and 22.5%, respectively. When comparing women with and without co-occurring affective symptoms, rates of symptom resolution and RTP were significantly lower in those with affective symptoms, and women with nervous-anxious symptoms spent significantly longer in
RTP progression. When comparing men with and without co-occurring affective symptoms, rates of symptom resolution and RTP were significantly lower in
those with co-occurring affective symptoms, and affective symptoms were not
associated with time in RTP progression.
Conclusion: Student-athletes with affective symptoms and nervous-anxious
symptoms exhibited delayed clinical recovery and RTP timelines, particularly for time in RTP. Symptom prevalence and concussion history contributed
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to this; however, unmeasured confounding remains, as indicated by the poor
model fit. This study motivates future work to explore affective symptoms and
RTP timelines, considering anxiety and risk/protective factors over time.
Keywords: affective symptoms; anxiety; athletics; female; mild TBI; symptomology; traumatic brain injury

S

port-related concussion (SRC) is a relatively common injury in
collegiate athletic populations; from 2009 to 2014, SRCs accounted
for 6.2% of athletic injuries across the National Collegiate Athletic
Association (NCAA)—a 5-year injury rate of 4.47 per 10,000 athlete
exposures.51 Increases in rates over time can likely be attributed to
improved detection and ease of reporting of incident cases of SRC
through emergent university, athletic conference, and national-level
surveillance studies,23,37,51 in addition to developments in guidelines
and protocols for managing SRC.10,32,33
Symptom assessment, albeit subjective, is one of the most common
management practices after SRC, employed during initial injury evaluation (86.7%), return to learn, and return to play (RTP) decision making (57.3%) by athletic trainers in a variety of settings.28 Subjective
symptom reports that include a symptom inventory, such as the Sport
Concussion Assessment Tool (SCAT-5), are important instruments in
identifying and managing athletes with concussions.12 However, athletes report various types of symptoms after SRC. Common symptoms reported by collegiate athletes after a concussion include headache (92.2%), dizziness (68.9%), difficulty concentrating (58.3%),
sensitivity to light (49.1%), and loss of balance50 (36.7%). Moreover,
symptom presentation often differs in women and men.4,5,11,18 Evidence
suggests that women exhibit more physical, somatic, and emotional
symptoms than men.16 Among collegiate athletes, women and those
with a history of concussion exhibit greater symptom severity in the
initial 3 days after injury, relative to men,24 warranting further exploration of symptom experiences of student- athletes in women’s and
men’s sports separately. Further, almost one-third of collegiate athletes (30.7% [32.6% women; 29.5% men]) experience symptoms for
longer than 2 weeks, and over 20% (23% women; 19.9% men) endure
3 or more weeks of symptoms after concussion.8 In sport-specific analyses, such as a sample of Division 1 ice hockey players, women demonstrated significantly longer times to symptom resolution and RTP
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clearance than men.48 These findings support further study of symptom type and duration after a concussion among collegiate athletes
to understand underlying mechanisms and identify appropriate and
actionable management approaches.
Besides female sex, researchers suggest that collegiate studentathletes with attention deficit hyperactive disorder, history of motion
sickness, and higher initial postinjury symptom scores present with
greater symptom severity within 2 weeks after SRC.24 In addition to
these risk factors, the total number and type of reported SRC symptoms themselves may relate to recovery after SRC. For example, in one
study, children with a higher symptom burden indicated by the total
number and severity of symptoms at the time of injury, had a prolonged recovery— defined as symptom duration .28 days—compared
with children with a lower symptom burden.40 Similarly, in collegiate
athletes with a concussion, a greater symptom burden was related to
a longer time to symptom resolution.38 However, limited research has
examined whether the nature or type of symptom experience influences time to recovery outcomes (e.g., symptom resolution, return to
full play) in large samples of collegiate student-athletes. This work is
compelling and needed because identifying specific symptoms may aid
clinicians in easing symptom severity and/or recovery time throughout treatment, particularly in the presence of risk factors that are not
easily modifiable during concussion management.
There is growing awareness and clinical interest in examining athletes who experience affective symptoms after SRC, as these symptoms may contribute to overall postconcussive symptoms and represent a potentially modifiable risk factor for a longer recovery. For
example, adolescents with affective symptoms—including anxiety and
depression at baseline and after SRC—presented with higher symptom burden and poorer cognitive performance. 1 In a small sample of
collegiate athletes, Sicard et al.41 reported a greater affective symptom burden in athletes with slower symptomatic recovery compared
with asymptomatic athletes with a concussion and with noninjured
controls. Still, the relationship between anxiety and postconcussive
symptoms remains unclear; and limited empirical evidence in the collegiate athletic setting demonstrates the potential effects of experiencing affective symptoms on the entire RTP trajectory. Importantly,
previous work has demonstrated that symptom presence 4,5,11,16,18 and
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symptom resolution8,48 manifest differently between female and male
athletes, warranting independent study and analysis separately for
these groups. This study aimed to test whether affective symptom reporting and experiencing nervous-anxious symptoms in isolation are
related to RTP progression after SRC in Division 1 student-athletes and
among women and men separately. We hypothesized that those endorsing affective symptoms—specifically the nervous-anxious symptom—would spend a longer amount of time in RTP progression and
have a longer recovery after SRC.

Methods
Data Source
We used data from the Ivy League–Big Ten Epidemiology of Concussion Study (Ivy–B1G Study)—a prospective, multisite, observational
study and repository of student-athlete concussions across 19 Ivy
League–Big Ten universities— and included concussions reported in
varsity sports through February 2020. Since 2013, athletic trainers
and research coordinators identified athletes diagnosed with concussions across 19 participating campuses and collected and submitted
cases to the online study database registry. The data form consists of
3 sections about the athletes and their injury: (1) athlete demographic
information; (2) circumstances and mechanism of concussion injury
and clinical information, including symptomology; and (3) dates of
injury, symptom resolution, and return to learn and RTP outcomes.
Athletes consented to participation in the study at the beginning of
each academic year. The University of Pennsylvania institutional review board serves as the central institutional review board for this
study. This study follows the Strengthening the Reporting of Observational Studies in Epidemiology reporting guidelines for cohort studies.49 Previous publications outline the methods of the study in detail
and describe the overall cohort.13,37 Of note, we present our results referring to sex and using the terms ‘‘women/men’’ and ‘‘athletes on
women’s/men’s teams’’ throughout to reflect how data are collected
in the Ivy–B1G Study. We refer to ‘‘female/male’’ athletes when citing previous literature.
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Operational Definitions
Symptom Experience. Athletic trainers and research coordinators recorded whether athletes experienced any symptoms from the SCAT22 symptom inventory at any point throughout their SRC recovery.
Here, we selected out the 4 affective symptoms (more emotional, irritability, sadness, and nervous-anxious) based on the Centers for Disease Control and Prevention’s Traumatic Brain Injury and Concussion
symptom matrix15,34 and previous literature, 2,25,26,35 and we compared
athletes in our cohort who reported experiencing these symptoms after SRC with those who did not—stratified by sex. We also examined
the recovery trajectories of female and male athletes who specifically
reported the nervous-anxious symptom.
Recovery Outcomes. We defined13,37 time to the outcome symptom resolution as the number of days between the date of concussion injury and the date when the athlete self-reported being symptom-free. We defined time to return to full play as the number of
days between concussion injury and the date the athlete was medically cleared by a physician within the sports medicine or athletics
department to return to full athletic participation.8 We also reported
on time in RTP progression—calculated as the number of days between the date of symptom resolution and the date of return to full
athletic participation—akin to when the athlete completed their stepwise RTP progression.
Statistical Analysis
We presented the prevalence of SRC to date across all sports and test
for between-sex differences by class year, age, symptom burden (number of symptoms endorsed/ SCAT-22 symptom inventory), and concussion history (≥1 self-reported previous concussions, diagnosed by
a medical provider) using Wilcoxon rank-sum tests and chi-square
tests for categorical variables. To determine the internal consistency
of our affective symptom domain, we calculated the Kuder-Richardson
coefficient for the 4 affective symptoms. We used logistic regression
to estimate the likelihood of reporting a nervous-anxious symptom.
With survival analysis, we estimated the time to the 3 outcomes of
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interest: (1) symptom resolution, (2) return to full play, and (3) time
in RTP progression. We reported the proportion of athletes whose RTP
occurred on the same day (0) and before (–) reporting symptom resolution. Crude and adjusted Kaplan-Meier curves with log-rank tests
presented and tested differences between symptom burden (median
number of symptoms; >11 or ≤11 symptoms) and between concussion
history (≥1 previous concussion) separately by sex. Student-athletes
were censored at the end of each academic year of participation; thus,
they may have reached their outcomes at a later date. Additional independent right censoring may have occurred in cases where athletes
were lost to follow-up at the end of an athletic season or from leaving sports or school altogether. We examined Kaplan-Meier curves for
violations of the proportional hazards assumption and assessed the
correlation between the scaled Schoenfeld residuals and time using
the Schoenfeld test.
We used Cox proportional hazards regressions to estimate hazard
ratios (i.e., rate ratios) for symptom resolution, return to full play, and
time in RTP progression during 7 weeks after injury in women and
men, separately. Our main predictor of interest was a 4-level categorical measure of symptoms experienced in the affective domain: (1) no
affective symptoms; (2) co-occurring affective symptoms— nervousanxious and irritability, and/or sadness, and/or more emotional; (3)
only nervous-anxious symptoms; and (4) no nervous-anxious symptoms—irritability and/or sadness and/or more emotional. We presented crude, univariate models and included non-affective symptom
burden, the number of 18 non-affective symptoms endorsed to mitigate the risk of multicollinearity, and concussion history (≥1) as covariates in the Cox multiple adjusted models.
As a second analysis, we used linear regression to model the
crude and adjusted relationship between our 4-level measure of affective domain and days in RTP progression by sex. Skewness and
kurtosis were tested to evaluate the RTP progression variable for
normality. The statistical analysis was performed using Stata 16.1
(StataCorp).43
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Results
SRC Prevalence
A total of 2077 SRCs (women, n = 759; men, n = 1318) occurred from
November 2013 to February 2020, across 25 varsity sports at participating sites (Appendix Table A1). For women, the top 3 sports with
the largest number of SRCs included soccer (n = 149 [19.6%]), lacrosse (n = 88 [11.6%]), and basketball (n = 78 [10.3%]). For men,
half of SRCs occurred in football (n = 665 [50.5%]), followed by wrestling (n = 127 [9.6%]) and lacrosse (n = 124 [9.4%]). The distribution
of SRCs was different across class year when injured (P = .03), with
the freshman year making up the largest proportion for women (n =
231 [30.6%]) and sophomore year making up the largest proportion
for men (n = 406 [31.0%]). The median age at the time of SRC was
different between women (median, 19; interquartile range [IQR], 1920) and men (median, 20; IQR, 19-21) (P < .001). Student-athlete SRC
characteristics are presented in Table 1.
Table 1 Student-Athlete SRC Characteristics a
Characteristic

Women

Men

Pb

Total
759 (36.5)
1318 (63.5)
Class yearc			
.03
Freshman
231 (30.6)
324 (24.8)
Sophomore
218 (28.8)
406 (31.0)
Junior
176 (23.3)
324 (24.8)
Senior
126 (16.7)
235 (18.0)
Fifth year
5 (0.7)
20 (1.5)
Age, y
19 (19-20)
20 (19-21)
< .001
Symptom burden
11 (7-15)
11 (7-15)
.93
Affective symptom domain,d yese
265 (47.6)
394 (44.3)
.23
Nervous or anxious symptom, yese
135 (24.2)
200 (22.5)
.45
Concussion history (≥1), yese
261 (46.9)
420 (47.2)
.89
a. Data are presented as median and interquartile range, or n (%). SRC, sport-related concussion.
b. Chi-square test; Wilcoxon rank-sum test.
c. Missing data: Women (n=3), Men (n = 9).
d. Affective domain symptoms: irritability, sadness, more emotional, and nervous
or anxious.
e. Among those who reported at least one symptom: Women (n = 556), Men (n = 889).
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Time to Recovery Outcomes
For women, the median times for symptom resolution, RTP, and RTP
progression were 10 (IQR, 4-14), 14 (IQR, 9-23), and 6 (IQR, 4-10)
days, respectively. For men, the median times to symptom resolution,
RTP, and RTP progression were 10 (IQR, 3-13), 11 (IQR, 9-20), and 6
(IQR, 4-10) days, respectively.
SRC Symptom Burden
The overall number of symptoms after SRC (symptom burden) was
comparable between sexes (median, 11 [IQR, 7-15]) (Table 1). Endorsing more symptoms (.11 symptoms) was associated with a median 5-day delay in time to symptoms resolving for women (11 vs
6 days; P < .0001) and men (10 vs 5 days; P < .0001) (Figure 1, A
and B). Stratified by concussion history, time to symptom resolution was significantly delayed among women with more symptoms
(P < .0001) (Figure 1, C and D ). Women with a higher symptom burden (.11 symptoms) and a history of concussion demonstrated the
longest median time to symptom resolution (12 days). Women with
lower symptom burden (≤11 symptoms) and no previous concussion exhibited the shortest median time to symptom resolution (5
days). Among men, higher symptom burden and no history of concussion demonstrated the longest median time to symptom resolution (10 days). Men with lower symptom burden without a history
of concussion exhibited the shortest median time to symptom resolution (4 days; P < .0001).
For return to full play, having higher symptom burden (>11 symptoms) was associated with a 6-day delay in women (median, 17 vs 11
days; P < .0001) and a 4-day delay in men (median, 15 vs 11 days; P <
.0001) (Figure 2, A and B). Stratified by concussion history, women
with a higher symptom burden and no concussion history had the
longest time to RTP (18 days). Women with lower symptom burden
and no history of concussion had the shortest RTP (median, 10 days)
(Figure 2C). Half of the men with a higher symptom burden with and
without a history of concussion returned to play within 16 and 15
days, respectively. Men with lower symptom burden with and without a history of concussion demonstrated the fastest return to full play
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Figure 1. Kaplan-Meier survival curves show differences in time to symptom resolution for (A) women with >11 symptoms (11 vs 6 days); (B) men with >11 symptoms (10 vs 5 days); (C) women with >11 symptoms and ≥1 previous concussion(s)
(12 days) or ≤11 symptoms and no previous concussions (5 days); and (D) men with
>11 symptoms and no previous concussions (10 days) or ≤11 symptoms and ≥1 previous concussion(s) (4 days). Median days and interquartile ranges (IQRs) are presented for the outcome symptom resolution. Log-rank tests compare differences by
symptom burden and concussion history.

(12 and 10 days, respectively [P = .0001]) (Figure 2D). Overall, time
to symptom resolution and full play among women with SRC was 1
to 2 days longer than men—regardless of symptom burden and concussion history.
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Figure 2. Kaplan-Meier survival curves show differences in time to return to full
play for (A) women with >11 symptoms (17 vs 11 days); (B) men with >11 symptoms (15 vs 11 days); (C) women with >11 symptoms and no previous concussions
(18 days), or ≥11 symptoms and no previous concussions (10 days); and (D) men
with >11 symptoms and ≥1 previous concussion(s) (16 days) or ≤11 symptoms with
no previous concussions (10 days). Median days and interquartile ranges (IQRs) are
presented for the outcome to return to full play. Log-rank tests compare differences
by symptom burden and concussion history.

Symptom Prevalence
The most commonly reported symptoms were headache (women,
96%; men, 94%), pressure in the head (women, 81%; men, 77%),
and don’t feel right (women, 80%; men, 81%) (Figure 3). Affective

D’Alonzo et al. in Am. Journal of Sports Medicine (2022)

12

Figure 3. Symptom prevalence among women and men. Symptoms are from the
Sport Concussion Assessment Tool–22 symptom inventory. SRC, sport-related
concussion.

symptoms were among the least common, with 20% to 40% of athletes reporting feeling more emotional, irritability, sadness, and
nervous-anxious after SRC. Affective symptoms had excellent internal consistency (women, α = .83; men, α = .82), indicating that they
are strongly correlated with each other in women and men. The number of athletes who reported at least 1 symptom within the affective domain was also comparable between women and men (women,
n = 265; men, n = 394) (P = .23). The nervous-anxious symptom always co-occurred with at least 4 other symptoms from the SCAT-22
for women and men. Overall, women were 40% (odds ratio [OR], 1.40
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[95% CI, 1.33-1.47]; P < .001) and men 33% (OR, 1.33 [95% CI, 1.261.40]; P < .001) more likely to report nervous-anxious symptoms with
each additional symptom they reported.
Affective Symptom Domain
Symptoms took the longest to resolve (median, 11 days) among women
with co-occurring affective symptoms, and those without affective
symptom endorsement exhibited the shortest time to symptom resolution (median, 6 days; P < .0001) (Figure 4A). Similarly, men endorsing co-occurring affective symptoms had the longest symptom
resolution time (median, 11 days), and those without affective symptoms had the shortest symptom duration (median, 5 days) (P<.0001)
(Figure 4B).
These patterns persisted for the outcome to return to full play.
Women with co-occurring affective symptoms demonstrated the longest time to return to full play (median, 19 days). Half of the women
with no affective symptoms returned within 12 days (P < .0001) (Figure 4C). Men with co-occurring affective symptoms demonstrated the
longest time to return to full play (19 days). Men with no affective
symptoms or only nervous-anxious symptoms were the first to return
to full play (median, 12 days; P = .002) (Figure 4D).
Time to Symptom Resolution
In the Cox multiple regression analysis, compared with women who
did not experience any affective domain symptoms, the rate of symptom resolution was 30% lower (hazard ratio [HR], 0.70 [95% CI,
0.54-0.91]; P < .01) for women with co-occurring affective symptoms,
36% lower (HR, 0.64 [95% CI, 0.40-1.04]; P = .07) for women who
experienced nervous-anxious symptoms only, and 26% lower (HR,
0.74 [95% CI, 0.59-0.92]; P < .01) for women who experienced other
affective symptoms without nervous-anxious symptoms, adjusting for
symptom prevalence (HR, 0.94 [95% CI, 0.92-0.96]; P < .001) and
history of concussion (HR, 0.73 [95% CI, 0.61-0.87]; P = .001). For
men, the adjusted model did not meet the proportional hazards assumption; complete results are presented in Table 2.
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Figure 4. Kaplan-Meier survival curves show differences in time to symptom resolution for (A) women with co-occurring affective symptoms (11 days) or no affective symptoms (6 days); (B) men with co-occurring affective symptoms (11 days) or
no affective symptoms (5 days); (C) return to full play for women with co-occurring
affective symptoms (19 days) or no affective symptoms (12 days); and (D) men with
co-occurring affective symptoms (19 days), no affective symptoms (12 days), or only
nervous-anxiety symptoms (12 days). Median days and interquartile ranges (IQRs)
are presented for the outcomes of symptom resolution and return to full play. Logrank tests compare differences by affective domain category.

Time to Return to Full Play
Compared with women who did not experience any affective domain
symptoms, the rate of return to full play was 46% lower (HR, 0.54
[95% CI, 0.41-0.71]; P < .001) for women with co-occurring affective symptoms, 28% lower (HR, 0.72 [95% CI, 0.40-1.29]; P = .27) for
women who experienced nervous-anxious symptoms only, and 29%
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Table 2. Cox Proportional Hazards Regression—Breslow Method for Tiesa
2.1 Outcome: Time to Symptom Resolution
			

Women 			

Variable

95% CI

HR

P

Men

HR

95% CI

P

Ref
0.58b
0.87
0.78b
0.93b
0.84

Ref
0.48-0.70
0.59-1.30
0.66-0.93
0.92-0.95
0.73-0.96

Ref
–.001
.50
.01
–.001
.01

Ref
0.79b
0.93b
0.95b
0.94b
0.83b

Ref
0.64-0.98
0.62-1.38
0.79-1.14
0.92-0.96
0.73-0.96

Ref
.03
.71
.62
–.001
.01

Univariate Cox Regression
Affective domain
No affective
Co-occur affective
Only nervous-anxious
No nervous-anxious
Symptom prevalence (18)
Concussion history (11)
Affective domain
No affective
Co-occur affective
Only nervous-anxious
No nervous-anxious
Symptom prevalence (18)
Concussion history (11)

Ref
0.53
0.63
0.63
0.93
0.76

Ref
0.42-0.66
0.39-1.01
0.50-0.78
0.91-0.95
0.64-0.91

Ref
–.001
.39
–.001
–.001
–.01

Cox Multiple Regression
Ref
0.70
0.64
0.74
0.94
0.73

Ref
0.54-0.91
0.40-1.04
0.59-0.92
0.92-0.96
0.61-0.87

Ref
–.01
.07
–.01
–.001
.001

2.2 Outcome: Time to Return to Full Play
			

Women			

Variable

95% CI

HR

P

Men

HR

95% CI

P

Ref
0.68
0.91
0.86
0.95b
0.87

Ref
0.55-0.83
0.60-1.39
0.71-1.03
0.93-0.96
0.75-1.01

Ref
–.001
.67
.10
–.001
.07

Ref
0.87
1.02
0.99
0.95b
0.87

Ref
0.68-1.11
0.66-1.55
0.82-1.21
0.93-0.97
0.75-1.01

Ref
.27
.94
.95
–.001
.07

Univariate Cox Regression
Affective domain
No affective
Co-occur affective
Only nervous-anxious
No nervous-anxious
Symptom prevalence (18)
Concussion history (11)
Affective domain
No affective
Co-occur affective
Only nervous-anxious
No nervous-anxious
Symptom prevalence (18)
Concussion history (11)

Ref
0.46
0.72
0.64
0.94b
0.89

Ref
0.36-0.59
0.40-1.28
0.51-0.80
0.92-0.96
0.74-1.07

Ref
–.001
.26
–.001
–0.001
.22

Cox Multiple Regression
Ref
0.54
0.72
0.71
0.97
0.85

Ref
0.41-0.71
0.40-1.29
0.55-0.91
0.94-0.99
0.71-1.03

Ref
–.001
.27
–.01
–.01
.09

(continued)
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Table 2. Continued
2.3 Outcome: Days in RTP Progression
			

Women			

Variable

95% CI

HR

P

Men

HR

95% CI

P

Ref
0.91
1.00
0.97
0.99
0.86

Ref
0.74-1.12
0.65-1.53
0.80-1.16
0.97-1.01
0.74-1.00

Ref
.38
.99
.72
.31
.06

Ref
0.93
1.00
0.99
0.99
0.87

Ref
0.73-1.19
0.65-1.55
0.82-1.21
0.97-1.01
0.74-1.01

Ref
.57
.99
.95
.61
.06

Univariate Cox Regression
Affective domain
No affective
Co-occur affective
Only nervous-anxious
No nervous-anxious
Symptom prevalence (18)
Concussion history (11)
Affective domain
No affective
Co-occur affective
Only nervous-anxious
No nervous-anxious
Symptom prevalence (18)
Concussion history (11)

Ref
0.63b
0.59
0.85
0.97
0.87

Ref
0.50-0.80
0.34-1.01
0.67-1.07
0.95-0.99
0.72-1.04

Ref
–.001
.06
.16
.02
.13

Cox Multiple Regression
Ref
0.65
0.61
0.86
0.99
0.85

Ref
0.49-0.84
0.35-1.06
0.67-1.10
0.97-1.02
0.71-1.02

Ref
.001
.08
.22
.63
.09

a. HR, hazard ratio; Ref, reference; RTP, return to play.
b. Did not meet proportional hazards assumption.

lower (HR, 0.71 [95% CI, 0.55-0.91]; P < .01) for women who experienced other affective symptoms without nervous-anxious symptoms,
adjusting for symptom prevalence (HR, 0.97 [95% CI, 0.94-0.99];
P < .01) and history of concussion (HR, 0.85 [95% CI, 0.71-1.03];
P = .09). For men, estimated HRs were 0.87 (95% CI, 0.68-1.11; P = .27)
for those with co-occurring affective symptoms, 1.02 (95% CI, 0.661.55; P = .94) for men who experienced nervous-anxious symptoms
only, and 0.99 (95% CI, 0.82-1.21; P = .95) for men who experienced
other affective symptoms without nervous-anxious symptoms, adjusting for symptom prevalence (HR, 0.95 [95% CI, 0.93-0.97]; P < .001)
and history of concussion (HR, 0.87; 95% CI, 0.75-1.01; P = .07).
Time in RTP Progression
RTP was reported to have occurred on the same day as symptom
resolution for 27 (1.87%) student-athletes and RTP occurred before
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symptom resolution for 12 (0.83%) student-athletes. Compared with
women who did not experience any affective domain symptoms, the
rate of time in RTP progression was 35% lower (HR, 0.65 [95% CI,
0.49- 0.84]; P = .001) for women with co-occurring affective symptoms, 39% lower (HR, 0.61 [95% CI, 0.35-1.06]; P = .08) for women
who experienced nervous-anxious symptoms only, and 14% lower
(HR, 0.86 [95% CI, 0.67-1.10]; P = .22) for women who experienced
other affective symptoms without nervous-anxious symptoms, adjusting for symptom prevalence (HR, 0.99 [95% CI, 0.97-1.02]; P = .63)
and history of concussion (HR, 0.85 [95% CI, 0.71- 1.02]; P = .09). For
men, estimated HRs were 0.93 (95% CI, 0.73-1.19; P = .57) for those
with co-occurring affective symptoms, 1 (95% CI, 0.65-1.55; P = .99)
for men who experienced nervous-anxious symptoms only, and 0.99
(95% CI, 0.82-1.21; P = .95) for men who experienced other affective
symptoms without nervous-anxious symptoms, adjusting for symptom prevalence (HR, 0.99 [95% CI, 0.97-1.01]; P = .61) and history of
concussion (HR, 0.87 [95% CI, 0.74- 1.01]; P = .06).
In the secondary analysis of the number of days in RTP progression
using linear regression, women who reported experiencing nervousanxious symptoms alone spent, on average, 38 days (β = 38.46 [95%
CI, 7.11-69.80]; P = .02) longer in RTP progression than those who
reported no affective symptoms, holding other covariates constant.
Women with co-occurring affective symptoms took, on average, 10 additional days in RTP progression; however, this was not statistically
significant. For men, the measures of anxiety and days in RTP progression were not associated. For women and men, history of ≥1 previous concussion(s) was significantly associated with a longer mean
time in RTP progression: 15 days (β = 14.60 [95% CI, 3.94-23.29];
P < .01; R2 = 0.03) for women and 7 days (β = 6.90 [95% CI, 3.4218.24]; P = .02; R2 = 0.01) for men. Overall, the fit of the linear models was poor; results are presented in Appendix Table A2.

Discussion
This study extends previous literature examining the influence of
higher symptom burden on concussion recovery outcomes by assessing the role of affective symptom reporting overall, and the nervous
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or anxious symptom alone on timelines to symptom resolution and
return to full play outcomes after SRC. We explored these relationships separately among women and men in a homogeneous sample
of student-athletes, collected via a large, multisite surveillance study
of SRC in the Ivy League–Big Ten athletic conferences.
Our findings suggest that the total number of symptoms during recovery from SRC did not differ by sex; however, both women and men
experiencing .11 symptoms endured a 5-day delay in symptom resolution compared with those with fewer symptoms. Headache, pressure
in the head, and don’t feel right were the most commonly reported
symptoms, whereas affective symptoms were the least common in
women and men alike which is comparable with a previous report of
collegiate student-athletes with SRC.25 Although 20% to 40% of concussed athletes experienced affective symptoms, women and men were
40% and 33%, respectively, more likely to experience nervous-anxious
symptoms with each additional symptom endorsed. For women and
men, athletes with no affective symptoms experienced the fastest median recovery; in contrast, those experiencing nervous-anxious symptoms that co-occurred with at least 1 other affective symptom demonstrated the longest recovery outcomes. These results suggest that
total symptom burden may not be the only factor for longer recovery
times after SRC; however, symptom type does matter and may direct
modifiable efforts to prevent prolonged recovery.
We observed a significant association between higher symptom
burden paired with concussion history and longer times to symptom
resolution and return to full play for women and men. These results
are unsurprising because previous literature suggests that children
and collegiate athletes with a higher symptom burden experience longer recovery.24,40 Other factors, including female sex, attention deficit hyperactive disorder, and history of migraines, may be influential
in an athlete’s recovery timeline 24; however, these factors are not as
easily modifiable during concussion management, warranting continued study. Regardless of these risk factors, women lag behind men
in their time to symptom resolution and return to full play. These results reflect previous findings that identify sex differences in overall
clinical recovery timelines. 6-8,48 Importantly, contrasting findings suggest recovery differences do not exist when controlling for injury severity,22 the level of contact and division of play,31 sport,19 faster initial
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evaluation,36 earlier presentation to specialized care,20 or clearance
from a medical provider.9 This may highlight differences in concussion
management between women and men (or even a need in women) at
earlier stages and warrants further attention, as both displayed seemingly similar time in their RTP progression (median, 6 days) in the
present study. We found that women with affective symptoms, including experiencing nervous-anxious symptoms, appeared in RTP progression longer than those without nervous-anxious symptoms, emphasizing the importance of identifying symptom type in addition to
total symptoms to modify concussion management efforts.
Aligning with previous studies,50 we found that female and male
athletes commonly experienced headaches, pressure in the head, don’t
feel right, feeling slowed down, and feeling in a fog; some researchers highlight the emotional response that athletes experience after
a concussion relative to controls.29,47 In our sample, 20% to 40% of
athletes experienced 1 or more affective symptoms—including more
emotional, irritability, sadness, and nervous-anxiousness—and the
likelihood of experiencing nervous-anxious symptoms significantly
increased with each additional symptom. A recent study on children
with preexisting, diagnosed anxiety disorders reported greater symptom burden and delayed recovery outcomes (e.g., symptom resolution, return to school, and return to physical activity) after a concussion compared with those without anxiety disorders.30 Alternatively,
Ali et al.1 reported that in those with diagnosed depression or anxiety, the existence of premorbid depression or anxiety alone did not
influence postinjury cognitive or symptom recovery; yet, those with
preexisting conditions treated with antidepressants had higher symptom burden and worse cognitive scores after a concussion. Although
the present study did not account for preexisting conditions or medication (prescription or usage), we see that those who reported experiencing affective symptoms, including nervous- anxious symptoms,
demonstrated significant delays in time to symptom resolution and
timelines to return to full play. A higher symptom burden overall and,
importantly, the collection of affective symptoms seems to drive this
delay, as endorsing the nervous-anxious symptom alone is comparable with endorsing any other of the affective symptoms. This finding
supports the importance of assessing comorbid affective symptoms, as
these may influence recovery outcomes after SRC. A study of healthy
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participants at baseline assessment demonstrated worse scores for attention and processing speed in athletes with comorbid depression or
anxiety symptoms compared with controls.44 It seems that affective
symptoms may also influence cognitive performance outcomes even
in athletes without a concussion, indicating that the presence of comorbid affective symptoms should be a consideration during concussion management.
We found that men and women with no affective symptom experienced during their SRC recovery demonstrated the fastest recovery. Specifically, men and women with no affective symptoms had a
median symptom resolution in 5 and 6 days, respectively, and both
returned to play in a median of 12 days after SRC. Relative to those
without affective symptoms, men and women experiencing nervousanxious symptoms alone both had a median 3-day delay in symptom
resolution, and those with nervous-anxious and co-occurring affective symptoms experienced symptoms a median 4 days longer. These
results align with previous literature suggesting that athletes who
are slow to recover from their concussion demonstrate higher affective symptom burden, measured with the Beck Depression Inventory–
II, relative to asymptomatic concussed athletes and non-concussed
control athletes.41 In addition, in a study by Turner et al.,46 upward
of 70% of concussed athletes exceeded the threshold of clinical state
anxiety—defined as a score ≥38 on the State-Trait Anxiety Inventory
for Adults42—acutely after their injury. However, over half of athletes
still displayed state anxiety above clinical thresholds at RTP, suggesting that affective symptoms may last longer than other symptom subtypes.46 Moreover, in a study of adults with concussions seen by a primary care physician or emergency department, premorbid psychiatric
conditions (e.g., depression and anxiety) were a predictor of longer
recovery, along with older age, comorbid personality disorders, and
preinjury health care utilization.27 Similarly, pediatric patients, aged
12 to 18 years, with preexisting emotional distress (e.g., depression
and anxiety) exhibited longer symptom resolution relative to patients
without a history of depression or anxiety.39 Importantly, the authors
also reported that girls and women experienced longer recovery times
as well as higher percentages of preexisting anxiety compared with
men. However, this study included patients presenting to a specialty
concussion clinic at a median of 16 days after injury. Therefore, the
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aforementioned studies may not be representative of student-athletes
experiencing SRC in the collegiate-athletic setting. One cross-sectional
between-group study of collegiate athletes found that concussion was
associated with elevated anxiety, but not attentional bias to threat —
defined as focused awareness of threat-related stimuli, which has been
considered a hallmark symptom, and in some cases, a potential causal
factor of anxiety.14 Authors suggest that this has important implications for understanding not only the nature and source of anxiety after a concussion, but also the best treatment options, and they urge
further studies to investigate these complex relationships.14 Alternatively, Covassin et al.17 demonstrated the importance of social support
in mitigating state anxiety after a concussion, as concussed athletes
with greater satisfaction with social support had lower state anxiety
levels, particularly at RTP time in concussed athletes. Further, in a
qualitative study, Todd et al.45 showed how ice hockey players experienced extreme feelings of compromised identity after a concussion,
exacerbated by feelings of isolation and stigmatization. Participants
cited support from peers, family, and health care providers as key to
their success moving forward after an injury.45 Therefore, adding social support and psychological intervention practices integrated into
concussion management may benefit athletes, especially those with
affective and persisting symptoms.
These findings also have important implications for detection and
identification for treatment, as feeling nervous or anxious, or rather
anxiety itself, has clear screening, diagnostic, and management protocols that can be integrated into concussion management. Still, existing
studies that have evaluated affective symptoms, specifically anxiety,
after concussion have focused on the acute postconcussion period; few
have considered the role of preinjury or long-term symptoms.3,21 Thus,
additional work is needed to determine the appropriate type and timing of affective symptom assessments, and how they can best be applied in different settings and contexts, alongside clinical judgment.
However, in contexts where formal screening and/or diagnostic measures may not be feasible, it may prove useful to first utilize and inspect symptom assessment tools used during SRC management (e.g.,
SCAT-22) to help identify athletes after SRC who may be at risk for
prolonged symptoms and recovery—as demonstrated here.
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Limitations
Our study makes important contributions by examining the role of
affective symptoms on timelines to symptom resolution, RTP, and
time within RTP progression after SRC, highlighting key differences
among athletes in women’s and men’s sports; however, some limitations must be considered. In modeling the relationship between experiencing symptoms in the affective domain and time to symptom resolution among men, our Cox multiple regression model did not meet
the proportionality assumption; thus, our estimate of the rate ratio
cannot be assumed to be constant throughout the follow-up time. In
this case, alternative survival analysis methods may be more appropriate and will be explored in future analyses. For the outcome time
in RTP progression, linear regression models demonstrated poor fit
among women (R2 = 0.03) and men (R2 = 0.01), suggesting that there
are additional, uncontrolled factors contributing to time in RTP progression among athletes with anxiety. This warrants continued study
of student-athletes experiencing longer recovery to identify potential
preventative/actionable factors. We were not able to consider preexisting mental health conditions, anxiety/depression screening assessments or previous/ current receipt of mental health services; thus,
future research should consider their relationship with recovery outcomes. We were limited to considering symptom burden, as symptom
data from the Ivy-B1G Study are collected via a dichotomized checklist from the SCAT–22 inventory. We hope that this analysis inspires
future examinations of symptom severity among those who endorse
affective symptoms. In addition, consideration should be given to the
temporality of experiencing the nervous- anxious symptom and timedependency of this exposure and potential covariates; it may be that
higher symptom burden and/or experiencing symptoms over a longer period exacerbates feelings of nervousness and anxiousness and/
or anxiety. Attention should also be given to potential sources of nervous-anxious symptoms, particularly if they are related to the athlete’s injury and/or RTP.
The Ivy League and Big Ten conferences include programs where
SRC detection and management protocols are enforced, requiring immediate removal of athletes with suspected or reported SRC, and injured athletes are progressed through RTP protocols. Therefore, this
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study extends research on patients presenting to emergency departments, primary care, and specialty clinics, while limiting the generalizability beyond similar athletic conferences to other competitive divisions and levels of play.

Conclusion
Affective symptom endorsement was relatively common in collegiate
athletes after SRC, and these symptoms do play a role in delayed clinical recovery and RTP. Differences were evident among both female
and male athletes, particularly with total time in RTP progression. Collegiate sports are a unique setting where the breadth and timeliness
of health care resources after injury may differ compared with previous studies of patients seeking care for prolonged symptoms at specialty clinics. By identifying the nature and extent of collegiate athletes who experience affective and nervous-anxious symptoms after
SRC, we afford clinical care teams opportunities to prioritize and mobilize mental health resources and tailor treatments to athletes. The
factors measured here (sex, symptom prevalence, and concussion history) contribute to this relationship; however, significant unmeasured
confounding remains, as indicated by the poor fit of our Cox and linear models. This study establishes a precedent for future work to explore affective symptoms and RTP timelines, considering the role of
anxiety and other risk/protective factors collected over time.
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APPENDIX
Table A1. Sport-related Concussions Across Varsity Sports
for Academic Years 2013-14 to 2019-20 (November 2013 through February 2020)
Sport
football
soccer
lacrosse
basketball
wrestling
gymnastics
volleyball
field hockey
water polo
sprint football
softball
baseball
swimming
track&field/cross country
diving
rowing
fencing
squash
sailing
cheerleading
skiing
tennis
equestrian
polo
golf

Women
(n=759, 36.5%)
0 (0.0)
149 (19.6)
88 (11.6)
78 (10.3)
0 (0.0)
73 (9.6)
69 (9.1)
71 (9.4)
30 (4.0)
0 (0.0)
58 (7.6)
0 (0.0)
26 (3.4)
17 (2.2)
19 (2.5)
15 (2.0)
7 (0.9)
12 (1.6)
12 (1.6)
10 (1.3)
7 (0.9)
7 (0.9)
8 (1.1)
2 (0.3)
1 (0.1)

Men
(n=1318, 63.5%)
665 (50.5)
118 (9.0)
124 (9.4)
70 (5.3)
127 (9.6)
7 (0.5)
6 (0.5)
0 (0.0)
40 (3.0)
59 (4.5)
0 (0.0)
38 (2.9)
8 (0.6)
17 (1.3)
7 (0.5)
6 (0.5)
10 (0.8)
4 (0.3)
3 (0.2)
3 (0.2)
2 (0.2)
2 (0.2)
0 (0.0)
1 (0.1)
1 (0.1)

Total
(n=2077, 100%)
665 (32.0)
267 (12.9)
212 (10.2)
148 (7.1)
127 (6.1)
80 (3.9)
75 (3.6)
71 (3.4)
70 (3.4)
59 (2.8)
58 (2.8)
38 (1.8)
34 (1.6)
34 (1.6)
26 (1.3)
21 (1.0)
17 (0.8)
16 (0.8)
15 (0.7)
13 (0.6)
9 (0.4)
9 (0.4)
8 (0.4)
3 (0.1)
2 (0.1)

Table A2. Linear regression
Outcome: days in RTP progression
Women
Variable
Univariate linear regression
Affective domain
No affective
Co-occur affective
Only nervous-anxious
No nervous-anxious
Symptom prevalence (18)
Concussion history
Multivariable linear regression
Affective domain
No affective
Co-occur affective
Only nervous-anxious
No nervous-anxious
Symptom prevalence (18)
Concussion history
Abbreviation: CI=confidence interval

Men

β

95% CI

p-value

ref
10.82
38.41
3.83
0.72
14.44

ref
-2.90-24.54
7.15-69.67
-9.49-17.15
-0.58-2.02
3.74-25.15

ref
0.12
0.02
0.57
0.28
<0.01

ref
9.66
38.46
3.06
0.21
14.60

ref
-5.99-25.32
7.11-69.80
-10.80-16.91
-1.28-1.70
3.94-23.29

ref
0.23
0.02
0.67
0.78
<0.01

2

R

0.02
0.002
0.01

0.03

β

95% CI

p-value

ref
4.00
-4.71
-0.10
0.07
6.80

ref
-3.80-11.79
-20.46-11.05
-6.93-6.74
-0.58-0.71
1.30-12.31

ref
0.31
0.56
0.98
0.84
0.02

ref
4.90
-3.71
-0.15
-0.16
6.90

ref
-4.05-13.86
-19.57-12.14
-7.40-7.10
-0.92-0.60
3.43-18.24

ref
0.28
0.65
0.97
0.68
0.02

R2

0.002
0.008
0.007

0.01

